argenx SE (0QW0)
LSE
Closed
Aug 24, 2026
Day's Range
858.4052 wk Range
567.50Overview - 0QW0 - argenx SE
Key Statistics
Valuation
Enterprise Value
19.86B
P/E (Trailing)
‪42.42‬
Price / Sales (TTM)
‪62.98‬
Price / Book
‪17.50‬
EV / EBITDA
‪-54.02‬
Profitability
Gross Margin
‪90.42%‬
Profit Margin
‪-47.51%‬
Operating Margin
‪-63.52%‬
Return on Assets
‪-10.29%‬
Return on Equity
‪-13.62%‬
Ownership
Shares Outstanding
62.53M
Float
55.49M
Held by Insiders
‪0.00%‬
Held by Institutions
‪37.76%‬
Price stats
Beta
‪0.52‬
50-Day Avg
‪780.82‬
200-Day Avg
‪719.86‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 0QW0 - argenx SE
Peers - 0QW0 - argenx SE
Peer Comparison
Compared with companies in Biotechnology listed on LSE.
- 0QW0LSEargenx SE52.61BMarket Cap+34.75%52-week change42.42P/E (Trailing)‪-47.51%‬Profit Margin
- 0MGBLSEGenmab A/S173.69BMarket Cap+27.59%52-week change30.65P/E (Trailing)‪29.01%‬Profit Margin
- 0QZULSEVertex Pharmaceuticals Incorporated140.34BMarket Cap+29.12%52-week change0.58P/E (Trailing)‪34.99%‬Profit Margin
- 0R2MLSERegeneron Pharmaceuticals, Inc.90.49BMarket Cap+31.55%52-week change0.12P/E (Trailing)‪27.86%‬Profit Margin
- 0A45LSEModerna, Inc.72.10BMarket Cap+82.56%52-week change55.34P/E (Trailing)‪11.32%‬Profit Margin
- 0NZTLSEUCB SA44.92BMarket Cap+9.47%52-week change128.71P/E (Trailing)‪6.45%‬Profit Margin
- 0K91LSENorthern Trust Corporation40.97BMarket Cap+29.60%52-week change0.26P/E (Trailing)‪24.67%‬Profit Margin
Profile Summary - 0QW0 - argenx SE
About
argenx SE is a commercial-stage, global, fully-integrated biopharmaceutical company headquartered in Amsterdam, Netherlands, specializing in the development of differentiated antibody-based therapies for severe autoimmune diseases. The company leverages its Immunology Innovation Program (IIP), a discovery engine that…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
